Genetic Test Evaluation

understanding how genetic tests impact patient management

Prolaris Post-Prostatectomy (Myriad Genetic Laboratories Inc.)

April 19, 2019

This report evaluates the analytical validity, clinical validity, and clinical utility of the Prolaris Post-Prostatectomy test. According to Myriad Genetics Laboratories Inc., the Prolaris Post-Prostatectomy test is intended for diagnostic analysis of formalin-fixed paraffin-embedded (FFPE) tissue from resected prostate tumors for determination of biochemical recurrence risk within 10 years after prostatectomy.